Merck & Co Inc

MRK

$76.18

+0.1% (1 year change)

Market Cap

$195 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$15.19 - $85.00

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

27.72x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$2.53 (3.29%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $195 Billion
Enterprise Value $219 Billion
Dividend Yield $2.53 (3.29%)
1 Year Return +3.4%
52-Week High $85.00
52-Week Low $15.19
Beta 0.44
Outstanding Shares 2.53 Billion
Avg 30 Day Volume 8.28 Million

Valuation

P/E Ratio 27.72
PEG -2230.8
Earnings per Share $2.64
Price to Sales Ratio 4.23
Price to Book Ratio 7.62
Revenue to Enterprise Value 4.56
EBIT to Enterprise Value 26.28
Total Debt to Enterprise Value 0.14
Debt to Equity 1.16

Profitability

Revenue $48 Billion
Gross Profit $32.2 Billion
EBIT $8.34 Billion
Net Income $7.03 Billion
Profit Margin 14.63%
Quarterly Earnings Growth (YoY) -1.2%
Return on Equity 26.08%
Return on Assets 7.73%
Return on Invested Capital 12.93%

News

Fertility Drug Market Value Projected to Expand by 2027 | Pfizer, Merck

Fertility Drug Market Value Projected to Expand by 2027 | Pfizer, Merck

Coronavirus isn''t just a worldwide pandemic and general wellbeing emergency; it has additionally seriously influenced the worldwide economy and monetary business sectors. Critical decreases in pay...

OpenPR OpenPR, about 24 hours ago
Europe Pancreatic Cancer Therapy Market Deals, Price, Revenue, Gross Margin and Market Share 2021-2027| Eli Lilly and Company,F. Hoffmann-La Roche Ltd,Amgen Inc,Novartis AG,Celgene Corporation,Merck & Co., Inc,Pharmacyte Biotech Inc,Clovis Oncology

Europe Pancreatic Cancer Therapy Market Deals, Price, Revenue, Gross Margin and Market Share 2021-2027| Eli Lilly and Company,F. Hoffmann-La Roche Ltd,Amgen Inc,Novartis AG,Celgene Corporation,Merck & Co., Inc,Pharmacyte Biotech Inc,Clovis Oncology

A report added on the Business Market Insights, titled Europe Pancreatic Cancer Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2027 covers several well-known organizatio...

OpenPR OpenPR, 2 days ago
Advisors Asset Management, Inc. Buys Virtus Dividend, Interest & Premium Strategy Fund, ...

Advisors Asset Management, Inc. Buys Virtus Dividend, Interest & Premium Strategy Fund, ...

Related Stocks: MRK , SHOP , AMGN , SQ , GS , WMT , NFJ , NIE , ACV , NCZ , NCV , SZC , RTX , GLO , GME , TGT , PWR , EW ,

GuruFocus GuruFocus, 4 days ago